Skip to main content

Drug Interactions between alglucosidase alfa and Pombiliti

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

alglucosidase alfa cipaglucosidase alfa

Applies to: alglucosidase alfa and Pombiliti (cipaglucosidase alfa)

If you are starting treatment with cipaglucosidase alfa after being on alglucosidase alfa, your doctor will generally not start it until close to or at the same time you would have received your next dose of alglucosidase alfa. If you received medications before your previous doses of alglucosidase alfa, your doctor may want you to receive the same pre-medications before you receive your infusion of cipaglucosidase alfa. Make sure your doctor is aware of your history with alglucosidase alfa before you start treatment with cipaglucosidase alfa. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Agents for pompe disease

Therapeutic duplication

The recommended maximum number of medicines in the 'agents for Pompe disease' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'agents for Pompe disease' category:

  • alglucosidase alfa
  • Pombiliti (cipaglucosidase alfa)

Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer